Eggermont, A., Chiarion-Sileni, V., Grob, J., Dummer, R., Wolchok, J. D., Schmidt, H., . . . Testori, A. (2016). Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. The New England journal of medicine, 375(19), . https://doi.org/10.1056/NEJMoa1611299
Chicago Style (17th ed.) CitationEggermont, Alexander, et al. "Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy." The New England Journal of Medicine 375, no. 19 (2016). https://doi.org/10.1056/NEJMoa1611299.
MLA (9th ed.) CitationEggermont, Alexander, et al. "Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy." The New England Journal of Medicine, vol. 375, no. 19, 2016, https://doi.org/10.1056/NEJMoa1611299.
Warning: These citations may not always be 100% accurate.